SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-035585
Filing Date
2012-05-10
Accepted
2012-05-10 08:31:50
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a12-8800_110q.htm 10-Q 493722
2 EX-31.1 a12-8800_1ex31d1.htm EX-31.1 11080
3 EX-31.2 a12-8800_1ex31d2.htm EX-31.2 11302
4 EX-32.1 a12-8800_1ex32d1.htm EX-32.1 7504
  Complete submission text file 0001104659-12-035585.txt   2006752

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT path-20120331.xml EX-101.INS 158713
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT path-20120331.xsd EX-101.SCH 17104
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT path-20120331_cal.xml EX-101.CAL 30686
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT path-20120331_lab.xml EX-101.LAB 289055
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT path-20120331_pre.xml EX-101.PRE 128002
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT path-20120331_def.xml EX-101.DEF 82437
Mailing Address 227 WASHINGTON STREET SUITE 200 CONSHOHOCKEN PA 19428
Business Address 227 WASHINGTON STREET SUITE 200 CONSHOHOCKEN PA 19428 484-567-0130
NUPATHE INC. (Filer) CIK: 0001375200 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34836 | Film No.: 12827827
SIC: 2834 Pharmaceutical Preparations